In CRC, systemic inflammatory response, as evidenced by increased serum CRP and decreased serum albumin (mGPS) or increased blood neutrophil/lymphocyte ratio, indicates adverse prognosis17. The gene discussed is CRP; the disease is colorectal carcinoma.